Reported results
- Revenue was $129.1 million for the three months ended September 30, 2026.
- GAAP Net loss was $9.2 million, representing basic and diluted loss per share of $0.09, for the three months ended September 30, 2026.
- Non-GAAP Adjusted EBITDA was $34.2 million for the three months ended September 30, 2026.
- GAAP Net Cash Provided by Operating Activities was $154.2 million for the nine months ended September 30, 2026.
- Non-GAAP Discretionary Cash Flow was $150.0 million for the nine months ended September 30, 2026.
- Capital expenditures were approximately $246 million for the three months ended September 30, 2026.
Guidance
- Full year 2026 total revenue is expected to be between $435 and $445 million.
- Full year 2026 non-GAAP Adjusted EBITDA is expected to be between $105 and $115 million.
- Full year 2026 Total Capital Expenditures are expected to be between $490 and $510 million, excluding acquisitions.
- Exiting 2027, the Company projects annualized revenue exceeding $750 million and non-GAAP annualized Adjusted EBITDA above $300 million.
Price and volatility reaction
The stock moved -2.6% on the print. No front-expiry chain was on file, so there is no straddle expected move.
| Measure | Value | Basis |
|---|---|---|
| Close before release | 11.36 | 2026-11-06 |
| Close after release | 11.06 | 2026-11-09 |
| Realised move | -2.6% | close to close |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-09 (8-K, Item 2.02). Read the original filing on sec.gov.
